Szela Mary T 4/A

What Happened

• Mary T. Szela, a director of Absci Corporation (ABSI), received equity awards on June 4, 2026: 8,400 restricted stock units (RSUs) and 33,200 stock options. Both awards were granted at a $0 exercise/purchase price (i.e., no cash paid at grant). This Form 4 is an amendment correcting the originally reported award amounts.

Key Details

• Transaction date: 2026-06-04 (original Form 4 filed June 8, 2026; amended June 15, 2026 to correct amounts).
• Awards: 8,400 RSUs (reported as "A" — award/grant) and 33,200 stock options (derivative award).
• Price: $0.00 per share/option at grant (no immediate cash exchange).
• Vesting: Both the RSUs and the options vest in full on the earlier of (i) the first anniversary of the grant or (ii) the issuer’s next annual meeting of stockholders, subject to Szela’s continuous service (per footnotes F1 and F2).
• Shares owned after the transaction: Not disclosed in this filing.
• Filing status: Amended Form 4 to correct amounts; original filing appears timely (filed within required reporting window), amendment filed 2026-06-15.

Context

• RSUs: Each RSU represents the right to receive one share upon vesting and settlement. No shares are delivered until vesting conditions are met.
• Stock options: Options give the holder the right to buy shares in the future (subject to vesting and any exercise price); this filing reports the grant, not an exercise or sale.
• These are typical director compensation awards and do not indicate an immediate sale or purchase in the open market.